1 Issue per year
The journal collaborates with the following conferences:
2nd Antibody Drug Conjugates Conference 24th-25th October 2016 in Boston, USA
Non-Genetic Inheritance (NGI) is an international journal devoted to the rapid publication of works of wide significance and originality in all areas of the growing field of transgenerational epigenetic inheritance:
- Animal, plant and microbial reproduction and development: transgenerational epigenetic reprogramming, gametogenesis, maternal and paternal effects
- Health / therapeutic applications of non-genetic inheritance; multi-generational epidemiological data, transgenerational effects of environmental exposures such as toxins, ionising radiation and diet, gestational programming, intervention strategies to prevent inherited epigenetic disease, implications for assisted reproductive technology
- Agricultural / commercial implications of non-genetic inheritance: transgenerational stress memory in plants, influence of non-genetic inheritance on livestock health and breeding
- Evolutionary aspects of non-genetic inheritance: adaptive / nonadaptive significance of non-genetic inheritance, comparison and interplay between genetic and non-genetic inheritance
Our central goal is to provide a hub for researchers working across all species to present their discoveries, and to be a forum for the discussion of the important issues in the field. The journal accommodates a variety of exposition styles and formats to help scientists with diverse backgrounds interact.
Aims and Scope
Why subscribe and read
- medium for the publication of novel findings within the growing field of transgenerational epigenetic inheritance that are likely to advance the direction and thinking of the field.
- international forum for the dissemination of research data from diverse species; designed to facilitate the exchange of ideas between researchers working with different organisms.
- accommodates different styles and formats to help scientists from various backgrounds interact .
- transparent, comprehensive and fast peer review,
- free language-correction services for authors from non-English speaking regions.
- DE GRUYTER OPEN
- Emerging Science
- Type of Publication:
Submission of Manuscripts
Instructions for Authors
Last updated on 13 March 2014
Manuscripts should be submitted to the journal via online submission system Editorial Manager available for this journal at http://www.editorialmanager.com/ngi/. In case of problems, please contact the Journal Editor at email@example.com.
Authors are suggested to follow Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals from the International Committee of Medical Journal Editors (ICMJE).
Manuscript submitted to this journal should:
- contain original work - not published elsewhere in any medium (in the whole or in part) by the authors or anyone else and not under consideration for publication in any other medium;
- focus on the aims and scope of the journal;
- be clearly and correctly written - should contain all essential features of a scientific publication that is easy to understand for the target audience;
- written in English - attention to detail of the language will avoid severe misunderstandings which might lead to rejection of the paper;
- be delivered in electronic format.
The journal accepts the following publication formats:
- Research Articles
- Communications and Rapid Communications
- Reviews and Mini-Reviews
- Letters to the Editor and Amendments
The journal uses a closed single-blind peer review system (the names of the reviewers are hidden from the authors). Submitted manuscripts are reviewed by two or more experts. Reviewers are asked to recommend whether a manuscript should be accepted, revised or rejected. Although the journal uses the plagiarism detection system CrossCheck, reviewers should alert the editors if they suspect any issues relating to author misconduct such as plagiarism.
Reviewers are asked to provide detailed, constructive comments that will help both the editors make a decision on the publication and the author(s) to improve their manuscript. They should point out whether the work has serious flaws that preclude its publication, or whether additional experiments should be carried out or additional data should be collected to support the conclusions drawn.
It is important that authors include a cover letter with their manuscript. Please explain why you consider your manuscript as suitable for publication in the journal, why will your paper inspire the other members of your field, and how will it drive research forward.
The letter should contain all important details such as:
- your full name (submitted by)
- full title of article and short title
- full list of authors with affiliations
- e-mail of the corresponding author
- contact address, telephone/fax numbers of the corresponding author
- number of attached files, if there is more than one
- status: new, reviewed or accepted (with reference ID if reviewed or accepted)
Cover letter should explicitly state that the manuscript (or one with substantially the same content, by any of the authors) has not been previously published in any language anywhere and that it is not under simultaneous consideration or in press by another journal. If related work has been submitted, then we may require a preprint to be made available. Reviewers will be asked to comment on the overlap between the related submissions.
Manuscripts that have been previously rejected, or withdrawn after being returned for modification, may be resubmitted if the major criticisms have been addressed. The cover letter must state that the manuscript is a resubmission, and the former manuscript number should be provided.
Conflict of interest declaration
To ensure fair and objective decision-making, authors must declare any associations that pose a conflict of interest in connection with evaluated manuscripts (see Editorial Policy for details). Authors are encouraged to fill in the ICMJE Conflicts of Interest Form (available here) and send it in the electronic format to the Journal Editor.
Open Access License
Authors have to sign an Open Access License that is available on the journal webpage. We encourage the authors to send the signed license along with the manuscript. Please note, that no article will be published unless the Open Access License is signed.
We accept submission of text, tables and figures as separate files or as a composite file. For your initial submission, we recommend you upload your entire manuscript, including tables and figures, as a single PDF file. If you are invited to submit a revised manuscript, please provide us with individual files: an editable text and publication-quality figures.
- Text files can be submitted in the following formats: MS Word - standard DOCUMENT (.DOC) or RICH TEXT FORMAT (.RTF); PDF (not applicable for re-submitted or accepted manuscripts, see below)
- Tables should be submitted as MS Word or PDF (not applicable for re-submitted or accepted manuscripts, see below). Please note that a straight Excel file is not an acceptable format
- Graphics files can be submitted in any of the following graphic formats: EPS; BMP; JPG; TIFF; GIF or PDF. Please note that Powerpoint files are not accepted
Post acceptance, text files of the revised manuscript and tables are required for use in the production.
Authors should clearly indicate location of tables and figures in the text if these elements are given separately or at the end of the manuscript. If this information is not provided to the editorial office, we will assume that they should be left at the end of the text.
For further instructions, please carefully follow the guidelines described in Instructions for Authors.
Abstracting & Indexing
Non-Genetic Inheritance is covered by the following services:
- Baidu Scholar
- Chemical Abstracts Service (CAS) - CAplus
- Chemical Abstracts Service (CAS) - SciFinder
- CNKI Scholar (China National Knowledge Infrastructure)
- DOAJ (Directory of Open Access Journals)
- EBSCO (relevant databases)
- EBSCO Discovery Service
- Google Scholar
- KESLI-NDSL (Korean National Discovery for Science Leaders)
- Meta (formerly Sciencescape)
- Naviga (Softweco)
- Primo Central (ExLibris)
- ProQuest (relevant databases)
- Summon (Serials Solutions/ProQuest)
- Ulrich's Periodicals Directory/ulrichsweb
- WanFang Data
- WorldCat (OCLC)
Neil Youngson, University of New South Wales, Sydney, Australia
Etienne Bucher, University of Basel, Switzerland
Editorial Advisory Board
Sir Peter Gluckman,University of Auckland, New Zealand
Ueli Grossniklaus, Institute of Plant Biology, Zurich, Switzerland
Eva Jablonka, Tel-Aviv University, Israel
Steve Jacobsen, University of California, Los Angeles, U.S.A
Randy Jirtle, Duke University, North Carolina, U.S.A.
William G Kelly,Emory University, Atlanta, U.S.A
Lambert H. Lumey, Columbia university, New York, U.S.A.
Michael Meaney, McGill University, Montreal, Canada
Stephen Krawetz, Wayne State University School of Medicine, Detroit, U.S.A.
Antoine Peters, Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland
Wolf Reik, University of Cambridge, UK
Carmen Sapienza, Temple University, Philadelphia, U.S.A
Michael Skinner, Washington State University, U.S.A
Azim Surani, Gurdon Institute, Cambridge University, U.K.
Emma Whitelaw, La Trobe University, Melbourne, Australia
Alyson Ashe, The Wellcome Trust and Cancer Research UK Gurdon Institute, Cambridge University, U.K.
Angela Crean, University of New South Wales, Sydney, Australia
Michelle Holland, Queen Mary University of London, UK
Adam Nelson, Howard Hughes Medical Institute, Harvard University, Massachusetts, U.S.A
Ruth Pidsley, The Garvan Institute of Medical Research, Sydney, Australia
Joanna M Youngson, Australian Bone Marrow Donor Registry, Alexandria, Australia
DE GRUYTER OPEN
Bogumiła Zuga 32A Str.
01-811 Warsaw, Poland
T: +48 22 701 50 15